Diabetes Management and Outcomes among Patients with Type 2 Diabetes Attending a Renal Service

Background. Patients with comorbid type 2 diabetes mellitus (T2DM) and renal disease, particularly those treated with insulin, often require complex pharmacological treatment and management of other diabetes complications. Aims. To assess the achievement of metabolic targets and compare the current...

Full description

Saved in:
Bibliographic Details
Main Authors: Elizabeth Skalkos, Rohit Rajagopal, David Simmons
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2023/1969145
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832547975930314752
author Elizabeth Skalkos
Rohit Rajagopal
David Simmons
author_facet Elizabeth Skalkos
Rohit Rajagopal
David Simmons
author_sort Elizabeth Skalkos
collection DOAJ
description Background. Patients with comorbid type 2 diabetes mellitus (T2DM) and renal disease, particularly those treated with insulin, often require complex pharmacological treatment and management of other diabetes complications. Aims. To assess the achievement of metabolic targets and compare the current management of renal service attenders with insulin- and noninsulin-treated T2DM. Methods. Single-centre retrospective cross-sectional study involving medical record review of patients with T2DM aged ≥18 years who visited a metropolitan renal outpatient clinic in 2017. Univariable analysis and multivariable logistic regression were used to identify factors associated with insulin treatment. Results. Among 268 patients (45.5% insulin-treated), mean HbA1c was higher in insulin-treated vs. noninsulin-treated patients (8.0±1.8% (64 mmol/mol) vs. 6.8±1.2% (51 mmol/mol), p<0.001). Significantly fewer insulin-treated patients had HbA1c≤7.0% (53 mmol/mol; 31.8% vs. 69.3%, p<0.001). More insulin-treated patients had ischaemic heart disease (46.7% vs. 33.6%, p=0.028), diabetic foot disease (15.6% vs. 4.8%, p=0.003), retinopathy (40.2% vs. 11.0%, p<0.001), and emergency attendance for severe hypoglycaemia (3.8% vs. 0% p=0.042). Insulin treatment was more associated with chronic kidney disease stages 4-5 (adjusted odds ratio (aOR) 2.41, 95% CI 1.07-5.43), retinopathy (aOR 3.10, 95% CI 1.04-9.27), and podiatry review (aOR 5.06, 95% CI 1.20-21.38). Only 38 (14.2%) individuals were seen by a colocated public multidisciplinary diabetes service in 2017. Conclusions. Renal clinic attenders with T2DM, particularly if insulin-treated, remained at increased risk of diabetes-related complications, including severe hypoglycaemia, with limited input from the colocated hospital diabetes team. Approaches to increase coordination of diabetes care among renal patients should be investigated.
format Article
id doaj-art-34414cbff74a410ab4fcae35c0c30527
institution Kabale University
issn 2314-6753
language English
publishDate 2023-01-01
publisher Wiley
record_format Article
series Journal of Diabetes Research
spelling doaj-art-34414cbff74a410ab4fcae35c0c305272025-02-03T06:42:45ZengWileyJournal of Diabetes Research2314-67532023-01-01202310.1155/2023/1969145Diabetes Management and Outcomes among Patients with Type 2 Diabetes Attending a Renal ServiceElizabeth Skalkos0Rohit Rajagopal1David Simmons2School of MedicineMacarthur Diabetes ServiceSchool of MedicineBackground. Patients with comorbid type 2 diabetes mellitus (T2DM) and renal disease, particularly those treated with insulin, often require complex pharmacological treatment and management of other diabetes complications. Aims. To assess the achievement of metabolic targets and compare the current management of renal service attenders with insulin- and noninsulin-treated T2DM. Methods. Single-centre retrospective cross-sectional study involving medical record review of patients with T2DM aged ≥18 years who visited a metropolitan renal outpatient clinic in 2017. Univariable analysis and multivariable logistic regression were used to identify factors associated with insulin treatment. Results. Among 268 patients (45.5% insulin-treated), mean HbA1c was higher in insulin-treated vs. noninsulin-treated patients (8.0±1.8% (64 mmol/mol) vs. 6.8±1.2% (51 mmol/mol), p<0.001). Significantly fewer insulin-treated patients had HbA1c≤7.0% (53 mmol/mol; 31.8% vs. 69.3%, p<0.001). More insulin-treated patients had ischaemic heart disease (46.7% vs. 33.6%, p=0.028), diabetic foot disease (15.6% vs. 4.8%, p=0.003), retinopathy (40.2% vs. 11.0%, p<0.001), and emergency attendance for severe hypoglycaemia (3.8% vs. 0% p=0.042). Insulin treatment was more associated with chronic kidney disease stages 4-5 (adjusted odds ratio (aOR) 2.41, 95% CI 1.07-5.43), retinopathy (aOR 3.10, 95% CI 1.04-9.27), and podiatry review (aOR 5.06, 95% CI 1.20-21.38). Only 38 (14.2%) individuals were seen by a colocated public multidisciplinary diabetes service in 2017. Conclusions. Renal clinic attenders with T2DM, particularly if insulin-treated, remained at increased risk of diabetes-related complications, including severe hypoglycaemia, with limited input from the colocated hospital diabetes team. Approaches to increase coordination of diabetes care among renal patients should be investigated.http://dx.doi.org/10.1155/2023/1969145
spellingShingle Elizabeth Skalkos
Rohit Rajagopal
David Simmons
Diabetes Management and Outcomes among Patients with Type 2 Diabetes Attending a Renal Service
Journal of Diabetes Research
title Diabetes Management and Outcomes among Patients with Type 2 Diabetes Attending a Renal Service
title_full Diabetes Management and Outcomes among Patients with Type 2 Diabetes Attending a Renal Service
title_fullStr Diabetes Management and Outcomes among Patients with Type 2 Diabetes Attending a Renal Service
title_full_unstemmed Diabetes Management and Outcomes among Patients with Type 2 Diabetes Attending a Renal Service
title_short Diabetes Management and Outcomes among Patients with Type 2 Diabetes Attending a Renal Service
title_sort diabetes management and outcomes among patients with type 2 diabetes attending a renal service
url http://dx.doi.org/10.1155/2023/1969145
work_keys_str_mv AT elizabethskalkos diabetesmanagementandoutcomesamongpatientswithtype2diabetesattendingarenalservice
AT rohitrajagopal diabetesmanagementandoutcomesamongpatientswithtype2diabetesattendingarenalservice
AT davidsimmons diabetesmanagementandoutcomesamongpatientswithtype2diabetesattendingarenalservice